PAPER Ma J, Tian Y, Du C, Zhu Y, Huang W, Ding C, Wei P, Yi X, Lin Z, Fang W

Cerium-doped Prussian blue biomimetic nanozyme as an amplified pyroptosis inhibitor mitigate Aβ oligomer-induced neurotoxicity in Alzheimer's disease.

J Nanobiotechnology. 2025 Mar 6;23(1):181. PubMed.

PAPER Chen HJ, Zhang M, Wei M, Yu X, Wang Y, Yang J, Li R, Zhao W, Wang X, Zhang S, Wang K, Bai T, Huo Y, Huang W, Dai Z, Ma G, Han Y, Chen G, Shu N

Amyloid pathology related to aberrant structure-function coupling of brain networks in Alzheimer's disease: insights from [18F]-florbetapir PET imaging.

Eur J Nucl Med Mol Imaging. 2025 Mar 7; Epub 2025 Mar 7 PubMed.

PAPER Rosal AE, Martin SL, Strafella AP

The role of Apolipoprotein E4 on cognitive impairment in Parkinson's disease and Parkinsonisms.

Front Neurosci. 2025;19:1515374. Epub 2025 Feb 20 PubMed.

PAPER Tasnády KR, Jehoul R, de Ravé MG, Gijbels MJ, Brône B, Dewachter I, Melotte V, Boesmans W

Gastrointestinal Dysfunction and Low-Grade Inflammation Associate With Enteric Neuronal Amyloid-β in a Model for Amyloid Pathology.

Neurogastroenterol Motil. 2025 Mar 6;:e15016. Epub 2025 Mar 6 PubMed.

PAPER Nie Y, Szebényi K, Wenger LM, Lakatos A, Chinnery PF

Origin and cell type specificity of mitochondrial DNA mutations in C9ORF72 ALS-FTLD human brain organoids.

Sci Adv. 2025 Mar 7;11(10):eadr0690. Epub 2025 Mar 7 PubMed.

PAPER Bobbins A, Davies M, Lynn E, Roy D, Yeomans A, Shakir SA

Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective.

Br J Clin Pharmacol. 2025 Mar 6; Epub 2025 Mar 6 PubMed.

PAPER Ng SI, Xu L, Mueller KD, Liss J, Berisha V

Segmental and Suprasegmental Speech Foundation Models for Classifying Cognitive Risk Factors: Evaluating Out-of-the-Box Performance.

Interspeech. 2024 Sep;2024:917-921. PubMed.

PAPER Yang Q, Sun H, Ma X, Tang L, Liu X, Huang X, Huang X, Chen Y, Tian D, Zeng X, Li N, Wang W, Fan D

Apolipoprotein E genotype is associated with island sign in lobar intracerebral hemorrhage.

Front Neurol. 2025;16:1540307. Epub 2025 Feb 20 PubMed.

PAPER Zhang H, Kargilis D, Tropea T, Robinson J, Shen J, Brody EM, Brinkmalm A, Sjödin S, Berndt AJ, Carceles-Cordon M, Suh E, Van Deerlin VM, Blennow K, Weintraub D, Lee EB, Zetterberg H, Chen-Plotkin AS

Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes.

Ann Clin Transl Neurol. 2025 Mar 7; Epub 2025 Mar 7 PubMed.

PAPER Davidowitz EJ, Lopez P, Patel D, Jimenez H, Wolin A, Eun J, Adrien L, Koppel J, Morgan D, Davies P, Moe JG

Therapeutic Treatment With OLX-07010 Inhibited Tau Aggregation and Ameliorated Motor Deficits in an Aged Mouse Model of Tauopathy.

J Neurochem. 2025 Mar;169(3):e70025. PubMed.

PAPER Liu JJ, Wei F, Wang YD, Liu J, Xu BL, Ma SC, Yang JB

Ginseng and Polygonum multiflorum formula protects brain function in Alzheimer's disease.

Front Pharmacol. 2025;16:1461177. Epub 2025 Feb 20 PubMed.

PAPER Steeves A, Faig K, McGibbon C, Sexton A, Jarrett P

Assessing Cognition Remotely: Expanding the Reach of Cognitive Testing for Older Adults at Risk for Dementia in a Randomized Controlled Trial.

Can Geriatr J. 2025 Mar;28(1):87-90. Epub 2025 Mar 1 PubMed.

PAPER Mahoney JR, Ayers E, Verghese J

Visual-somatosensory integration as a novel behavioral marker of amyloid pathology.

Alzheimers Dement. 2025 Mar;21(3):e14561. PubMed.

PAPER Li W, Zhou J, Li S, Wu M, Zhu Y, Chen Q, Chen F, Ma X, Zhang X, Wang Z, Lu J, Zhang B

Odor induced functional connectivity alteration of POC-anterior frontal cortex-medial temporal cortex in patients with mild cognitive impairment.

Front Aging Neurosci. 2025;17:1502171. Epub 2025 Feb 20 PubMed.

PAPER Jiang Y, Jin Z, Wang H, He X, Fu R, Yu X, Fu Q, Tian J, Li W, Zhu X, Zhang S, Lu Y

A dose-response meta-analysis of physical activity and the risk of alzheimer's disease in prospective studies.

J Neurol. 2025 Mar 7;272(4):256. PubMed.